DLCO (Diffusion Capacity of the Lung for Carbon Monoxide) is a simple, non- invasive pulmonary function test essential for diagnosing & managing interstitial lung disease, COPD and pulmonary vascular conditions.
DLCO measures how well gases like oxygen diffuse across the alveolar-capillary membrane. It uses a low-concentration CO gas in a single-breath maneuver & evaluates the rate of gas transfer from lungs to blood.
Key Concepts:
India has rising prevalance of ILD’s, post-tuberculosis lung disorders and post-COVID lung fibrosis. DLCO is especially valuable for respiratory physicians in Tier 2 & Tier 3 cities lacking HRCT access. Growing use in pre-operative assessments, smokers and occupational lung disease surveillance.
Insert Flowchart: Patient Referral > Pre-Test > DLCO Test > Report
DLCO Usage in India:
● 45% ILD diagnosis
● 30% COPD evaluation
● 15% Post-COVID fibrosis monitoring
● 10% Pre-surgical risk assessment
NOTE: Always correct for haemoglobin levels & adjust for altitude.
NOTE: Always correct for haemoglobin levels & adjust for altitude.
Advantages over Spirometery alone: